1. You are here:
  2. BioIndustry Association
  3. Member profile: Astex Pharmaceuticals
Astex logo web.png

Astex Pharmaceuticals

Drug Discovery

Website
http://www.astx.com
Membership category
Corporate

436 Cambridge Science Park, Milton Road, Cambridge, CB4 0QA,

Astex Pharmaceuticals at a glance

Astex is a leader in innovative drug discovery and development, committed to the fight against cancer and diseases of the central nervous system (CNS).

About Astex Pharmaceuticals

Astex Pharmaceuticals is a leader in innovative drug discovery and development, committed to the fight against cancer and diseases of the CNS. Astex is developing a proprietary pipeline of novel therapies and has multiple partnered products in development under collaborations with leading pharmaceutical companies. Astex is a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., based in Tokyo, Japan. Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: “Otsuka - people creating new products for better health worldwide.” Otsuka researches, develops, manufactures and markets innovative and original products, with a focus on pharmaceutical products for the treatment of diseases and nutraceutical products for the maintenance of everyday health. For more information about Otsuka Pharmaceutical, please visit www.otsuka.co.jp/en

Therapeutic area(s)

  • Small molecules
  • Neurology
  • Oncology

Articles Astex Pharmaceuticals has contributed to

1 June 2022

Astex Team A pedal their way up the #850Challenge leaderboard

This spring, Astex, a world-leading innovative drug discovery and development company, took part in the BIA Global 850 Challenge for Kidney Research UK. They split into two teams, Astex C (for Corporate) and Astex A (because “A sounds better than B”) and began their journey to reach 850! Throughout the challenge both Astex teams dominated the leaderboard, maintaining first and second place in terms of both distance covered and money raised. Read about Astex A’s experience participating in the #850Challenge.

Blog
1 June 2022

Astex Team C takes on the BIA Global 850 Challenge

This spring, Astex, a world leading innovative drug discovery and development company, took part in the BIA Global 850 Challenge for Kidney Research UK. They split into two teams, Astex C (for Corporate) and Astex A (because “A sounds better than B”) and began their journey to reach 850! Throughout the challenge both Astex teams dominated the leaderboard, maintaining first and second place in terms of both distance covered and money raised. Read about Astex C’s experience participating in the #850Challenge.

Blog